Clovis Shareholder Sues Over Directors' Lofty Pay
A Clovis Oncology Inc. shareholder on Wednesday told the Delaware Chancery Court in a derivative suit the biopharmaceutical company pays its directors more than twice as much as its competitors do...To view the full article, register now.
Already a subscriber? Click here to view full article